ID   U-1958
AC   CVCL_M494
DR   Wikidata; Q54973535
RX   DOI=10.1007/0-306-46877-8_4;
RX   PubMed=3580570;
RX   PubMed=10936422;
CC   Characteristics: Produces IgG kappa.
CC   Doubling time: 60 hours (PubMed=3580570).
CC   Derived from site: In situ; Pleural effusion; UBERON=UBERON_0000175.
CC   Cell type: Plasma cell; CL=CL_0000786.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_M493 ! U-1957
SX   Male
AG   60Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 14-08-25; Version: 12
//
RX   DOI=10.1007/0-306-46877-8_4;
RA   Jernberg-Wiklund, Helena
RA   Nilsson, Kenneth
RT   "Multiple myeloma cell lines.";
RL   (In book chapter) Human cell culture. Vol. 3. Cancer cell lines part 3; Masters, John R.W. & Palsson, Bernhard Orn (eds.); pp.81-155; Kluwer Academic Publishers; New York; USA (2000).
//
RX   PubMed=3580570; DOI=10.1182/blood.V69.6.1605.1605;
RA   Jernberg-Wiklund, Helena
RA   Nilsson, Kenneth
RA   Zech, Lore
RA   Lutz, D.
RA   Nowotny, Hadwiga
RA   Scheirer, Winfried
RT   "Establishment and phenotypic characterization of three new human
RT   myeloma cell lines (U-1957, U-1958, and U-1996).";
RL   Blood 69:1605-1612(1987).
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler, Hans Gunther
RA   Matsuo, Yoshinobu
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//